TTOO - T2バイオシステムズ （T2 Biosystems Inc.） T2バイオシステムズTTOOのチャート
TTOOの企業情報
| symbol | TTOO |
|---|---|
| 会社名 | T2 Biosystems Inc （T2バイオシステムズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 T2バイオシステム（T2 Biosystems Inc.）は体外診断会社である。同社は、既存の診断方法論に、迅速、高感度、簡単な代替手段を提供している技術プラットフォームを開発する。同社は自社のT2磁気共鳴プラットフォームを使用し、早速に医療専門家が治療上の意思決定を助けることを通じて、死亡率の低下、患者の転帰を改善、健康管理のコストを削減することを目標とする一連のアプリケーションを開発する。T2MRは、全血を含む浄化されていないいろいろな患者サンプルタイプで、病原体、バイオマーカーおよび他の異常の迅速な検出を可能にし、一つのコロニーミリリットル（CFU/ mL）の単位当たりの形成と低い検出限界での細胞標的を検出することができる。同社の次の2つの診断アプリケーションは、それぞれ細菌性敗血症感染症および止血に焦点を当てているT2BacteriaとT2HemoStatと呼ばれている。 T2バイオシステムズは、米国の医療機器メ―カ―。遺伝子診断装置の開発に従事。関節炎の一種であるライム病やカンジダ菌感染の自動分析装置｢T2MR｣や血液凝固分析装置｢T2HemoStat｣の開発に取り組む。本社はマサチュ―セッツ州レキシントン。 t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www |
| 本社所在地 | 101 Hartwell Avenue Lexington MA 02421 USA |
| 代表者氏名 | John McDonough ジョン・マクドノウ |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 781-457-1200 |
| 設立年月日 | 38808 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2014年 |
| 従業員数 | 161人 |
| url | www.t2biosystems.com |
| nasdaq_url | https://www.nasdaq.com/symbol/ttoo |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -46.39300 |
| 終値（lastsale） | 5.89 |
| 時価総額（marketcap） | 257791429.05 |
| 時価総額 | 時価総額（百万ドル） 207.45860 |
| 売上高 | 売上高（百万ドル） 9.01100 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 178.86360 |
| 当期純利益 | 当期純利益（百万ドル） -57.50700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 T2 Biosystems Inc revenues increased from $1.9M to $6.2M. Net loss decreased 16% to $25.2M. Revenues reflect Research revenue increase from $310K to $4M Product revenue increase of 66% to $2.3M. Lower net loss reflects Other Research and Development decrease of 43% to $7.4M (expense) Other Selling General and Administrativ decrease of 5% to $9.4M (expense). |
TTOOのテクニカル分析
TTOOのニュース
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday''s Mid-Day Session 2023/06/06 17:04:02 Benzinga
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT ) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. Hoth Therapeutics, Inc. (NASDAQ: HOTH ) rose 96% to $3.6850 after the company announced preclinical results for HT-ALZ for the treatment of Alzheimer''s disease. Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU ) shares rose 37.8% to $0.5928. Zura Bio Limited (NASDAQ: ZURA ) shares gained 25% to $8.11 after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist. Xunlei Limited (NASDAQ: XNET ) rose 22% to $1.6715. Xunlei launched a $20 million share buyback program. G-III Apparel Group, Ltd. (NASDAQ: GIII ) gained 21.7% to $20.13 following first-quarter results. G-III Apparel reported a master licensing partnership with Xcel Brands to design and produce all categories and distribute products globally for the Halston business and all of its brands.
Why Is Greenlane (GNLN) Stock Down 90% Today? 2023/06/06 12:45:38 InvestorPlace
Greenlane (NASDAQ: GNLN ) stock is falling hard on Tuesday as the company’s shares undergo a reverse stock split. This reverse stock split went into effect after markets closed on Monday. It saw shares of GNLN stock undergo a one-for-10 reverse stock split . This has it consolidating 10 shares of its Class A shares into a single share of stock. Greenlane isn’t undergoing this reverse stock split for no reason. The main purpose of the reverse split is to increase the price of GNLN stock . The company is doing so as its shares have been trading at around 30 cents each. That puts it in danger of being delisted due to the Nasdaq minimum bid requirement of $1 per share. Shares of GNLN stock saw a fair amount of activity yesterday as traders sold their shares ahead of the split. That had some 440,000 shares changing hands compared to its daily average of around 11,000 shares. Now it’s seeing massive pre-market trading on Tuesday with some 5.4 million shares on the move. What This Means For GNLN Stock While the reverse stock split helps Greenlane avoid delisting, it’s not going over well with investors today.
Why Is T2 Biosystems (TTOO) Stock Up 17% Today? 2023/06/06 12:28:25 InvestorPlace
T2 Biosystems (NASDAQ: TTOO ) stock is rising higher on Tuesday after the company revealed its submission for a Breakthrough Device Designation for its Candida auris test. The company has submitted its application for its Candida auris test to the Food and Drug Administration (FDA). It’s seeking Breakthrough Device Designation as it plans to add the test to its FDA-cleared T2Candida Panel. Candida auris is of major concern to those in the healthcare field as it has a mortality rate of up to 60%. This has prompted the Centers for Disease Control and Prevention ( CDC ) and the World Health Organization (WHO) to declare it a serious global health threat. Candida auris is a multidrug-resistant fungal pathogen. Considering its mortality rate, T2 Biosystems believes adding it to its T2Candida Panel would be a major boon to healthcare workers. That’s due to its ability to identify five variants of Candida species without having to wait days for a positive blood culture. How This Affects TTOO Stock Investors are excited about the prospect of the FDA granting T2 Biosystems Breakthrough Device Designation for the Candida auris test.
T2 Biosystems seeks FDA breakthrough designation for C. auris test 2023/06/05 18:18:13 Seeking Alpha
T2 Biosystems (TTOO) has submitted an application to the US Food and Drug Administration for breakthrough device designation for its Candida auris detection test. Read more here.
Why Is MDU Resources (MDU) Stock Moving Today? 2023/06/01 12:39:04 InvestorPlace
MDU Resources (NYSE: MDU ) stock is on the move Thursday alongside news of its spinoff joining the S&P MidCap 400 . According to MDU Resources, Knife River (NYSE: KNF ) is joining the S&P MidCap 400 when markets open this morning. This comes after the company announced plans to spin off the business last month. One thing for investors to note is that MDU Resources will continue to remain part of the S&P MidCap 400 even after the spinoff. This will bump Bank of Hawaii (NYSE: BOH ) off the S&P MidCap 400 to the S&P SmallCap 600 . It will also see HomeStreet (NASD: HMST ) remvoed from that same list. What About MDU Stock Falling? MDU Resources stock falling early on Thursday makes sense. With this spinoff, the company is losing value by separating Knife River out as its own business. However, it’s worth noting that about 90% of KNF shareholders will be current MDU shareholders. Investors will note that MDU stock isn’t seeing major activity on Thursday despite the spinoff going into effect.
Was anything positive for T2 Biosystems Inc. (TTOO) stock last session? 2023/03/06 15:08:00 US Post News
T2 Biosystems Inc. (NASDAQ:TTOO) closed Friday at $0.62 per share, up from $0.61 a day earlier. While T2 Biosystems Inc. has overperformed by 3.02%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TTOO fell by -96.94%, with highs and lows ranging from $29.25 to $0.54, whereas […]
T2 Biosystems to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023 2023/03/03 13:00:00 GlobeNewswire
LEXINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the fourth quarter and full year 2022 after market close on Monday, March 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Feel free to follow this:: T2 Biosystems, Inc. (NASDAQ:TTOO 1.06%), Onconova Therapeutics, Inc. (NASDAQ:ONTX -4.57%) 2023/02/25 12:39:47 Stock Equity
TTOO has seen its SMA50 which is now -60.06%. In looking the SMA 200 we see that the stock has seen a -88.14%. ONTX has seen its SMA50 which is … The post Feel free to follow this:: T2 Biosystems, Inc. (NASDAQ:TTOO 1.06%), Onconova Therapeutics, Inc. (NASDAQ:ONTX -4.57%) appeared first on Stocks Equity .
Enthralling stocks: T2 Biosystems, Inc. (NASDAQ:TTOO -16.25%), Tellurian Inc. (AMEX:TELL -8.61%) 2023/02/22 07:20:09 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enthralling stocks: T2 Biosystems, Inc. (NASDAQ:TTOO -16.25%), Tellurian Inc. (AMEX:TELL -8.61%) appeared first on Stocks Equity .
Mid-Day Stocks Roundup: Cryptyde, Inc. (NASDAQ:TYDE 0.46%), T2 Biosystems, Inc. (NASDAQ:TTOO -2.49%) 2023/02/21 17:17:33 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Mid-Day Stocks Roundup: Cryptyde, Inc. (NASDAQ:TYDE 0.46%), T2 Biosystems, Inc. (NASDAQ:TTOO -2.49%) appeared first on Stocks Equity .
T2 Biosystems innovative technology contract with Vizient extended 2022/12/28 14:40:01 Seeking Alpha
T2 Biosystems (TTOO) said Wednesday its innovative technology contract with healthcare performance improvement firm Vizient has been extended through March 31, 2024.Vizient members…
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday 2022/11/15 10:19:29 Benzinga
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT ) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share. Freight Technologies, Inc. (NASDAQ: FRGT ) shares climbed 113.6% to close at $0.4410 on Monday after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. ToughBuilt Industries, Inc. (NASDAQ: TBLT ) shares gained 72.3% to close at $3.79 after the company reported better-than-expected Q3 EPS results. Exela Technologies, Inc. (NASDAQ: XELA ) jumped 45.6% to close at $0.4048. Porch Group, Inc. (NASDAQ: PRCH ) rose 37.3% to close at $1.40. The compamy recently posted a wider-than-expected quarterly loss. Mercurity Fintech Holding Inc. (NASDAQ: MFH ) gained 36.1% to close at $0.7358. Clovis Oncology, Inc. (NASDAQ: CLVS ) rose 32.6% to close at $0.3846. Clovis Oncology recently warned of a possible bankruptcy amid liquidity concerns.
T2 Biosystems, Inc. (TTOO) Q3 2022 Earnings Call Transcript 2022/11/11 01:02:23 Seeking Alpha
T2 Biosystems, Inc. (NASDAQ:NASDAQ:TTOO) Q3 2022 Results Conference Call November 10, 2022 4:30 PM ET Company Participants Emma Poalillo - IR, Gilmartin Group John Sperzel - Chairman, CEO…
T2 Biosystems GAAP EPS of -$2.95 misses by $0.90, revenue of $3.68M misses by $1.05M 2022/11/10 21:10:08 Seeking Alpha
T2 Biosystems press release (TTOO): Q3 GAAP EPS of -$2.95 misses by $0.90.Revenue of $3.68M (-50.5% Y/Y) misses by $1.05M.Achieved sepsis and related revenue (non-COVID product…
T2 Biosystems Announces Third Quarter 2022 Financial Results 2022/11/10 21:05:00 T2 Biosystems
Achieves record quarterly sepsis and related revenue and advances product pipeline LEXINGTON, Mass. , Nov. 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced